Postdoctoral position is available to study the genomics of leiomyoma formation (uterine tumors, fibroids) and non-invasive diagnostics. The laboratory utilizes transgenic animals that model Med12 mutation, known to associate with 70% of human leiomyomas to study origin of leiomyomas, genomic rearrangements, epigenomics and cell types. Moreover, the laboratory is also analyzing human leiomyomas for cellular heterogeneity and non-invasive diagnostics. The laboratory utilizes molecular and cellular biological techniques, whole exome and genome sequencing, chromosomal microarrays, CRISPR generated humanized mouse animal models, and targeted knockouts. The candidate will also be exposed to human and animal experimentation.